Analysis of the Indian pharmaceutical industry with emphasis on opportunities in 2005

Pharmaceutical Technology

Volumn 27, Issue 1, 2003, Pages 74-94

  Joshi, Hemant N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL INDUSTRY; COMPETITION; MARKETING; PATENTS AND INVENTIONS;

PHARMACEUTICAL INDUSTRY;

DRUG PRODUCTS;

COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; INDIA; REVIEW; UNITED STATES;

EID: 0041506998     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. M.J. Ahn, "Developing a Profitable Market-Share Strategy for Multinational Pharmaceutical Companies in China," J. Pharm. Marketing and Management 13 (1), p. 29, (2000).
2. M. Szabo-Streit, The Pharmaceutical Market in Hungary, J. Pharm. Marketing and Management 13, 49-61 (1999).
3. "Korean Pharmaceutical Future Promising," Korea Times, 29 April 2001, http://www.Koreatimes.co.kr/14_1/199903/t415138.htm, 4/29/01.
4. A. Brichacek, "Top 50 Pharmaceutical Companies," Pharm. Exec. 21 (4) pp. 62-82 (2001).
5. "Department of Indian Systems of Medicines and Homeopathy Annual Report 1999-2000," http://indianmedicine.nic.in/.
6. Indian Drug Manufacturers' Association, 39th Annual Publication, 2001.
7. "Ranking of Indian Pharmaceutical Companies," http://www. indiainfoline.com/pharm/copo.html.
8. P.R. Cateora and J.L. Graham, International Marketing, (Irwin-McGraw Hill, New York, NY, 10th ed., 1999).
9. "Budget 2001," Impact Analysis, 8 March 2001, http://www.indiainfoline.com/bu01/bu02/impa/phar.html.
10. India Infoline Sector Reports, "Pharmaceuticals: Drug Price Control Order (DPCO)" http://www.indiainfoline.com/sect/phfo/ch06.html.
11. Dr. Reddy's to Acquire BMS Lab Subsidiary," 12 March 2002, http://www.indiainfoline. com/news/gene2002MAR12171157.html.
12. D.J. Ausman, "Screening's Age of Insecurity: High-Throughput Screening Hasn't Given Us More Drugs. Can Better Data Management Make a Difference?" Modern Drug Discovery, May 2001, 33-39.
13. W. Sadee, "Using Genetic Information to Individualize Drug Therapy: Implications of Pharmacogenetics-Pharmacogenomics," AAPS Newsmagazine 4 (April 2001), 18-21, 32-34.
14. S. Majumdar, Economic Review, end November, 6 December 2000, http://www.indiainfoline.com/nevi/ecov/index.html.
15. R.K. Srivastava, "How Many Indian Pharma Companies Will Survive after 2005?," 5 March 2002, http://www.indiainfoline.com/phar/ feat/homa.html.
16. P.V. Venugopal, "Industrial Property and the Pharmaceutical Industry: Opportunities and Challenges for Developing Countries," World Intellectual Property Organization (WIPO) Conference on Intellectual Property and Economic Development, Geneva, Switzerland, 3 June 1999.
17. The World Bank Group, "World Bank Says 'Big Five' Could Redraw Global Economic Map over Next 25 Years," News Release No. 98/1454, September 1997, http://www.worldbank.org/.
18. J.F. Tremblay, "Why Not India?," Chem. Eng. News, 7 May 2001, p. 25.
19. Organization of Pharmaceutical Producers of India, "Annual Drug Expenditure Per Capita in US Dollars," http://www.indiaoppi.comicannualchart.htm.
20. "The Management of Type II Diabetes: The Indian Consensus 2002, http://www.diabetesindia.com/diabetes/introduction_diabetes.htm.
21. B.L. Skinner, "Marketing in the New Millennium: A Refocus on Sales," J. Pharm. Marketing and Management 13, 73-80 (1999).
22. Dr. Reddy's Laboratory, "Discovery Pipeline and Licensing Opportunities, http://www.drreddys.com/drugproduct.html.
23. "Once-a-Day Formulations May Not Turn Into Big Brands, Say Analysts," 26 September 2001, http://www.pharmbiz.com/prodlaun/ p180-asp.